BioCopy
discovery and development of biotherapeutic drugs using an automated, AI-assisted end-to-end platform and is developing next-generation biotherapeutic drug candidates
Basel, Switzerlandwww.biocopy.com ↗
Total raised
€18M
€17,818,607
Funding rounds
2
Investors
0
distinct backers
Active since
2025-03
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDSignals
Medium confidenceRaise-next likelihood35
base rate 44% for Series A
- ▼ Raised very recently
- ▲ Up-round momentum
Exit likelihood9
base rate 12% (2+ rounds)
- ▼ Young (<3y)
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-01 | Series A | €9.8M | — | View deal → |
| 2025-03-20 | Other | €8.0M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy